The increasing impact of cancer on worldwide mortality makes the research of novel
chemotherapeutic agents a current and challenging issue. In the recent years, transition …

The utilization of photodynamic therapy (PDT) for the treatment of various types of cancer
has gained increasing attention over the last decades. Despite the clinical success of …

This review focuses on light-activated ruthenium anticancer compounds and the factors that
influence which pathway is favored. Photodynamic therapy (PDT) is favored by π expansion …

Photodynamic therapy (PDT) is a medical technique for the treatment of cancer. It is based
on the use of non-toxic molecules, called photosensitizers (PSs), that become toxic when …

Ruthenium complexes have been recently reported as potential chemotherapeutic agents
that offer tumor selectivity and low tumor resistance. This study investigates the …

Two readily synthesized water-soluble Sn (IV) porphyrins have been prepared with
quaternized pyridyl nitrogens and 2-naphthalato trans-axial ligands. Methyl and hexyl …

Photoactivated chemotherapy (PACT) is an emerging strategy for targeted cancer therapy.
Strained Ru complexes with pseudo-octahedral geometry may undergo photo-induced …

The synthesis and characterization of meso-tetra (thien-2-yl) chlorin (1) and meso-tetra (5-
bromothien-2-yl) chlorin (2) is reported. These dyes have red-shifted absorption maxima …

Photoactivated chemotherapy (PACT) is a form of target-oriented cancer therapy that
exploits light of the proper wavelength to selectively activate the drug. Among the prodrugs …

Protic ruthenium complexes using the dihydroxybipyridine (dhbp) ligand combined with a
spectator ligand (N, N= bpy, phen, dop, Bphen) have been studied for their potential activity …